In addition, using a genetic mouse model of medulloblastoma, Vanner et al. (2014) showed that Shh subgroup cells could maintain quiescent states during anti-mitotic chemotherapy through SOX2 positivity [224]. This evidence concerns the gene SOX2 and medulloblastoma.